1. |
Thompson AK, Juniper E, Meltzer EO. Quality of life in patients withallergic rhinitis. Ann Allerg Asthma Im, 2000, 85(22):338-348.
|
2. |
Asher MI, Montefort S, Bjorksten B, et al. Worldwide time trends in the prevalence of symptom of asthma, allergic rhinocojunctivitis, and eczema in childhood:ISAAC Phases One and Three repeat multicountry cross-section surveys. Lancet, 2006, 368(9537):733-743.
|
3. |
Wong GW, Hui DS, Chan HH, et al. Prevalence of respiratory and atopic disorders in Chinese school children. Clin Exp Allergy, 2001, 31(7):1225-1231.
|
4. |
Zhao J, Bai J, Shen K, et al. Self-reported prevalence of childhood allergic diseases in three cities of China:a multicenter study. BMC Public Health, 2010, 10(22):551.
|
5. |
Li J, Sun B, Huang Y, et al. A multicentre study assessing the prevalence of sensitization in patient with asthma and/or rhinitis in China. Allergy, 2009, 64(5):1083-1092.
|
6. |
王成硕, 张罗, 韩德民, 等.北京地区变应性鼻炎患者吸入变应原谱分析.临床耳鼻咽喉科杂志, 2006, 20(5):204-206.
|
7. |
Adrienne ML, Rodney JS, Sarah K, et al. Sublingual immunotherapy and quality of life. Curr Opin & Otolaryngol Head Neck Surg, 2013, 1(8):252-255.
|
8. |
Linnemann DEL. One hundred years of immnotherapy:review of the first landmark studies. Allergy Asthma Proc, 2012, 33(17):122-128.
|
9. |
Wise SK, Schlosser RJ. Subcutaneous and sublingual immunotherapy for allergic rhinitis:what is the evidence? Am J Rhinol Allergy, 2012, 26(11):18-22.
|
10. |
Wilson D, Lima MT, Durham SR. Sublingual immunotherapy for allergic rhinitis:systematic review and meta-analysis. Allergy, 2005, 60(1):4-12.
|
11. |
Higgins J, Green S. Cochrane handbook for systematic reviews of interventions Version 5.1.0[updated March 2011]. The Cochrane Collaborations, 2011. Available at:
http://www.cochrane.org/.
|
12. |
Hirsch Th, Sähn M, Leupold W. Double-blind placebo-controlled study of sublingual immunotherapy with house dust mite extract (D.pt.) in children. Pediatr Allergy Immunol, 1997, 8(9):21-27.
|
13. |
Bahceciler NN, Isik U, Barlan IB, et al. Efficacy of sublingual immunotherapy in children with asthma and rhinitis:a double-blind, placebo-controlled study. Pediatr Pulm, 2001, 32(21):49-55.
|
14. |
Ippoliti F, de Sanctis W, Volterrani A, et al. Immunomodulation during sublingual therapy in allergic children. Pediatr Allergy Immunol, 2003, 14(9):216-221.
|
15. |
Marcucci F, Sensi L, Frati F, et al. Effects on inflammation parameters of a double-blind, placebo controlled one-year course of SLIT in children monosensitized to mites. Allergy, 58(9):657-662, 2003.
|
16. |
曹兰芳, 陆权, 顾洪亮, 等.舌下含服粉尘螨滴剂治疗儿童过敏性哮喘和变应性鼻炎的临床评价.中华儿科杂志, 2007, 45(10):736-741.
|
17. |
Tseng SH, Fu LS, Nong BR, et al. Changes in serum specific IgG4 and IgG4/IgE ratio in mite-sensitized Taiwanese children with allergic rhinitis receiving short-term sublingual swallow immunotherapy:a multicenter, randomized, placebo-controlled trial. Asian Pac J Allergy Immunol, 2008, 26(2-3):105-112.
|
18. |
Yonekura S, Okamoto Y, Sakurai D, et al. Sublingual immunotherapy with house dust extract for house dust-mite allergic rhinitis in children. Allergol Int, 2010, 59(4):381-388.
|
19. |
de Bot CMA, Moed H, Berger MY, et al. Sublingual immunotherapy not effective in house dust mite-allergic children in primary care. Psdiatr Allergy Immunol, 2012, 23(7):150-158.
|
20. |
Aydogan M, Eifan AO, Keles S, et al. Sublingual immunotherapy in children with allergic rhinoconjuncticitis mono-sensitized to house-dust-mites:a double-blind-placebo-controlled randomized trial. Resp Med, 2013, 107(12):1322-1329.
|
21. |
Bousquet J, Khaltaev N, Cruz AA, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA (2) LEN and Allergen). Allergy, 2008, 63(Suppl 86):8-160.
|
22. |
Stoltz DJ, Jackson DJ, Evans MD, et al. Specfic patterns of allergic sensitization in early children and asthma & rhinitis risk. Clin Exp Allergy, 2013, 43(2):233-241.
|
23. |
Bousquet J, Lockey R, Mallingh J. Allergen immuno therapy:ther apeutic v accines for allergic diseases. Aller gy, 1998, 53(6):41-42.
|
24. |
Gary L, Elina T. Sublingual immunotherapy:what we can learn from the European experience. Curr Opin Otolaryngol Head Neck Surg, 2014, 22(3):208-210.
|
25. |
Pipet A, Botturi K, Pinot D, et al. Allergen-specific immunotherapy in allergic rhinitis and asthma. Mechanisms and Proof of Efficacy, 2009, 103(2):800-812.
|
26. |
Désirée L. Sublingual immunotherapy in children:complete and updated review supporting evidence of effect. Curr Opin Allergy Cl, 2009, 9(22):168-176.
|
27. |
Hoek SB, de Groot H, van Wijk RG. Immunotherapy in children and adolescents with allergic rhinoconjunctivitis:a systematic review. Pediatr Allergy Immunol, 2008, 19(2):197-207.
|
28. |
Gianenrico S, Marco C, Giorgio WC. Safety and tolerability of sublingual immunotherapy in clinical trials and real life. Curr Opin Allergy Clin Immunol, 2013, 13(11):656-662.
|
29. |
Penagos M, Compalati E, Tarantini F, et al. Efficacy of sublingual immunotherapy in the treatment of allergic rhinitis in pediatric patients 3 to 18 years of age:a meta-analysis of randomized, placebo controlled, double-blind trials. Ann Allergy Asthma Immunol, 2006, 97(12):141-148.
|
30. |
Compalati E, Passalacqua G, Bonini M, et al. The efficacy of sublingual immunotherapy for house dust mites respiratory allergy:results of a GA2LEN meta-analysis. Allergy, 2009, 64(11):1570-1579.
|
31. |
Bush RK, Swenson C, Fahlberg B, et al. House dust mite sublingual immunotherapy:result of a US trial. J Allergy Clin Immunol, 2011, 127(4):974-981.
|
32. |
Li F, Wu XL, Duan GW, et al. Regulatory T cells for long-lasting effect on asthmatic children caused by dermatophagoides farinae with sublingual imunotherapy. Chin J Appl Clin Pediatr, 2013, 28(9):673-675.
|
33. |
Ferres J, Justicia JL, GarcÍa MP, et al. Efficacy of high-dose sublingual immunotherapy in children allergic to house dust mites in real life clinical practice. Allergol Immunopathol (Madr), 2011, 39(3):122-127.
|
34. |
Rask C, Brimnes J, Lund K. Short dosing interval of sublingual immunotherapy lead to more efficacious treatment in a mouse model of allergic inflammation. Scand J Immunol, 2010, 71(8):403-412.
|
35. |
Palm NW, Rosenstein RK, Medzhitov R. Allergic host defences. Nature, 2012, 484(7395):465-472.
|
36. |
Passalacqua G, Durham SR. Allergic rhinitis and its impact on asthma update:allergen immunotherapy. J Allergy Clin Immunol, 2007, 19(4):881-891.
|